Midazolam Hydrochloride Injection, Solution
Product Images NDC 23155-601

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Midazolam Hydrochloride (NDC 23155-601). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Midazolam Spl 25mg Carton

Midazolam hydrochloride injection, USP 25 mg/5 mL (5 mg/mL) multiple-dose vials packaging label by Avet Pharmaceuticals Inc. The carton is for 10 vials of 5 mL each. The label indicates the product is for intramuscular or intravenous use and contains benzyl alcohol. NDC 23155-601-41, with batch details and bar code included. The label is predominantly green and white.*

FDA Label Image

Midazolam Spl 25mg Vial

Label for Midazolam hydrochloride Injection, USP 5 mg/mL (25 mg/5 mL) multiple-dose vial. The label states it is for intramuscular or intravenous use, sterile, and contains benzyl alcohol. Distributed by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. The label includes a barcode, lot and expiration fields, and manufacturing details including made in India and revision date 02/2020.*

FDA Label Image

Midazolam Spl 25per5ml Carton

Label for Midazolam hydrochloride Injection, USP 25 mg/5 mL (5 mg/mL) multiple-dose vials. The product is for intramuscular or intravenous use and contains benzyl alcohol. The label depicts a 10 x 5 mL vial carton with green and white color scheme, including NDC 23155-601 and Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. as the labeler. Storage and usage instructions, along with a barcode, are also visible.*

FDA Label Image

Midazolam Spl 25per5ml Container

Label for Midazolam Injection, USP 25 mg/5 mL (5 mg/mL) by Avet Pharma, a multiple-dose vial for intramuscular or intravenous use. The label includes formulation details, benzyl alcohol content, distributor information, barcode, lot, and expiration fields, and specifies the product is Rx only. Made in India.*

FDA Label Image

Midazolam Spl 50mg Carton

Midazolam Injection, USP 50 mg/10 mL (5 mg/mL) solution for injection by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. The label specifies intramuscular or intravenous use and contains benzyl alcohol. Packaging indicates 10 single-dose 10 mL vials. The label includes storage instructions, manufacturer information, and a barcode.*

FDA Label Image

Midazolam Spl 50mg Vial

Label for Midazolam Injection, USP, 50 mg/10 mL (5 mg/mL) in a 10 mL multiple-dose vial. The injection solution contains benzyl alcohol for sterility and is intended for intramuscular or intravenous use. Distributed by Avet Pharmaceuticals Inc., manufactured in India. Includes barcode and lot/expiration date area.*

FDA Label Image

Midazolam Spl 50per10ml Carton

Carton label for Midazolam hydrochloride Injection, USP 5 mg/mL (50 mg/10 mL) by Avet Pharma. It is a sterile solution for intramuscular or intravenous use containing benzyl alcohol, packaged as 10 x 10 mL multiple-dose vials. The label includes NDC 23155-601 and distributor information for Avet Pharmaceuticals Inc.*

FDA Label Image

Midazolam Spl 50per10ml Container

Label for Midazolam hydrochloride Injection, USP 50 mg/10 mL (5 mg/mL) solution for injection, indicated for intramuscular or intravenous use. The 10 mL multiple-dose vial label states it contains benzyl alcohol and is sterile. Distributed by Avet Pharmaceuticals Inc., East Brunswick, NJ, with manufacturing information and barcode also shown.*

FDA Label Image

Midazolam-spl-graph (Midazolam Spl Graph)

A line graph showing the pH dependence of the percentage of open-ring form in water. The x-axis represents pH values from 2.5 to 5.5, and the y-axis shows the percentage of open-ring form from 0 to 60%. The graph illustrates a decreasing trend of the open-ring form percentage as pH increases.*

FDA Label Image

Midazolam-spl-structure-01 (Midazolam Spl Structure 01)

Chemical structure diagram showing the conversion between Midazolam and its open-ring form. The image depicts two molecular structures with labeled atoms including chlorine, fluorine, and nitrogen in the heterocyclic rings, illustrating the ring opening reaction of Midazolam hydrochloride.*

FDA Label Image

Midazolam-spl-structure (Midazolam Spl Structure)

Chemical structure of Midazolam hydrochloride showing its fused ring system, including a chlorinated benzene ring and fluorine-substituted structure consistent with the active ingredient Midazolam hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.